Page last updated: 2024-09-03

y 27632 and Fatty Liver

y 27632 has been researched along with Fatty Liver in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amano, H; Hirata, K; Kimura, Y; Kobayashi, T; Kuroda, S; Mikuriya, Y; Ohdan, H; Tanaka, Y; Tashiro, H; Tsutada, M	1
Hibi, T; Horikawa, H; Ishii, H; Kitamura, K; Kumagai, N; Kurita, S; Nakamoto, N; Saito, H; Tada, S; Toda, K; Tsunematsu, S	1

Other Studies

2 other study(ies) available for y 27632 and Fatty Liver

Article	Year
Rho-kinase inhibitor targeting the liver prevents ischemia/reperfusion injury in the steatotic liver without major systemic adversity in rats. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2015, Volume: 21, Issue:1 Topics: Amides; Animals; Arterial Pressure; Cells, Cultured; Chemistry, Pharmaceutical; Choline Deficiency; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Hepatic Stellate Cells; Hypotension; Liposomes; Liver; Liver Circulation; Male; Portal Pressure; Protein Kinase Inhibitors; Pyridines; Rats, Wistar; Reperfusion Injury; rho-Associated Kinases; Time Factors	2015
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis. Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:11 Topics: Alanine Transaminase; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Choline Deficiency; Disease Models, Animal; DNA Damage; Fatty Liver; Liver; Liver Cirrhosis; Male; Organ Size; Oxidative Stress; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger; Signal Transduction; Tetrazoles; Time Factors; Tumor Necrosis Factor-alpha	2007

Article

Year

Rho-kinase inhibitor targeting the liver prevents ischemia/reperfusion injury in the steatotic liver without major systemic adversity in rats.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2015, Volume: 21, Issue:1

Topics: Amides; Animals; Arterial Pressure; Cells, Cultured; Chemistry, Pharmaceutical; Choline Deficiency; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Hepatic Stellate Cells; Hypotension; Liposomes; Liver; Liver Circulation; Male; Portal Pressure; Protein Kinase Inhibitors; Pyridines; Rats, Wistar; Reperfusion Injury; rho-Associated Kinases; Time Factors

2015

Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.

Journal of gastroenterology and hepatology, 2007, Volume: 22, Issue:11

Topics: Alanine Transaminase; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Choline Deficiency; Disease Models, Animal; DNA Damage; Fatty Liver; Liver; Liver Cirrhosis; Male; Organ Size; Oxidative Stress; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger; Signal Transduction; Tetrazoles; Time Factors; Tumor Necrosis Factor-alpha

2007